Retinalgenix Technologies is classified as operating in the N/A industry, NAICS Code .
Investor Activity
Retinalgenix Technologies has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
February 9, 2024
17
100%
$5 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Retinalgenix Technologies is developing and marketing.
Retinalgenix Technologies doesn't have any recent trademark applications, indicating Retinalgenix Technologies is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
RETINALGENIX DNA/RNA GPS Test kit, including lacrimal, nasal, buccal, and blood testing kits
10/19/2023
RETINALGENIX RNA GPS Test kit, including lacrimal, nasal, buccal, and blood testing kits
09/22/2023
RETINALGENIX DNA GPS Test kit, including blood testing kits
09/22/2023
See all trademarks and details in the Full Report.
Nearby Competitors
These companies are similar in business line and location to Retinalgenix Technologies.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Retinalgenix Technologies and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.